These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27605746)

  • 21. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prefilter and postfilter cysteine/cystine and copper concentrations in pediatric parenteral nutrition solutions.
    Cochran EB; Boehm KA
    JPEN J Parenter Enteral Nutr; 1992; 16(5):460-3. PubMed ID: 1433781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Wilson's disease].
    Kovacević I; Zekan M
    Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease.
    Lee HH; Hill GM; Sikha VK; Brewer GJ; Prasad AS; Owyang C
    J Lab Clin Med; 1990 Sep; 116(3):283-8. PubMed ID: 2401845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease.
    Lyon TD; Fell GS; Gaffney D; McGaw BA; Russell RI; Park RH; Beattie AD; Curry G; Crofton RJ; Gunn I
    Clin Sci (Lond); 1995 Jun; 88(6):727-32. PubMed ID: 7634759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum selenium concentration in patients with Wilson's disease.
    Swiatkowska-Stodulska R; Dejneka W; Jabłońska-Kaszewska I; Lukasiak J; Kiszkis H; Wiśniewski P; Lubińska M; Sworczak K
    Hepatogastroenterology; 2007 Sep; 54(78):1788-90. PubMed ID: 18019719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
    Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemolytic anaemia as first manifestation of Wilson's disease: a report of two cases.
    Santra G; Paul R; Choudhury PS; Ghosh SK; De D; Das S
    J Assoc Physicians India; 2014 Oct; 62(10):55-7. PubMed ID: 25906525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration.
    Moriarty-Craige SE; Adkison J; Lynn M; Gensler G; Bressler S; Jones DP; Sternberg P
    Am J Ophthalmol; 2005 Dec; 140(6):1020-6. PubMed ID: 16376645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.
    Cheah DM; Deal YJ; Wright PF; Buck NE; Chow CW; Mercer JF; Allen KJ
    Biometals; 2007 Oct; 20(5):751-7. PubMed ID: 17136311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings.
    Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G
    Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of sulfur amino acid utilization for GSH synthesis between HepG2 cells and cultured rat hepatocytes.
    Lu SC; Huang HY
    Biochem Pharmacol; 1994 Mar; 47(5):859-69. PubMed ID: 8135861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased uptake of L-cysteine and L-cystine by nerve growth factor in rat pheochromocytoma cells.
    Pan Z; Perez-Polo R
    Brain Res; 1996 Nov; 740(1-2):21-6. PubMed ID: 8973794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats.
    Muramatsu Y; Yamada T; Miura M; Sakai T; Suzuki Y; Serikawa T; Tanzi RE; Matsumoto K
    Gastroenterology; 1994 Oct; 107(4):1189-92. PubMed ID: 7926469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of L-cystine transport and intracellular GSH level by a nitric oxide donor in primary cultured rabbit conjunctival epithelial cell layers.
    Gukasyan HJ; Kannan R; Lee VH; Kim KJ
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1202-10. PubMed ID: 12601050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY
    J Am Coll Nutr; 1990 Oct; 9(5):487-91. PubMed ID: 2258535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.